fashion -WSS

fashion

author：hotspot 2025-09-28 01:34:44 - browse：9

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： What would happen to your eyes if you looked at the solar eclipse?

focus

WSS

Does Medicare's free annual wellness visit do any good?

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Calls for Trump's election interference trial to be televised part of long debate

Lifetime voting ban for felony convictions struck down in Mississippi

knowledge

fashion

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Does Medicare's free annual wellness visit do any good?

Alkermes shareholders re

Donald Trump's relentless attacks on special counsel Jack Smith

Guidelines to prevent youth baseball injuries need more muscle

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

At least 13 dead in Texas as scorching temps continue

Gene therapy has helped boys walk. Can scientists keep it that way?

Hollywood unions extend contract negotiations for actors

Disclosing genetic information: not as worrisome as once feared

explore

In areas with more Black doctors, Black people live longer

In areas with more Black doctors, Black people live longer

New company forms to vet health AI models, root out weaknesses

California Joshua trees severely burned in massive wildfire

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

With FDA staff opposed to Sarepta therapy, top official intervened

focus

hotspot

hotspot

focus